July.1,2024

LSI Medience and ACT Genomics Sign MOU to form a Strategic Partnership and Collaborate in the Japanese Market

Nov 1, 2023

The drug development support business was transferred to Mediford Corporation, a newly established company as a member of PHC Group, from November 1, 2023

Nov 1, 2023

The IVD business was integrated with PHC Corporation which was a subsidiary of PHC Holdings, from November 1, 2023.

June 27, 2023

LSI Medience Relocates a Representative Office in China

May 9, 2023

LSI Medience Opens a Representative Office in China

Oct.7, 2022

Announcing Relocation of Head Office

Sep.7, 2020

Reorganization of Non-clinical business

May.15,2020

COVID-19 Testing Started in the Philippines

Mar.9,2020

Accepting tests orders for novel coronavirus (SARS-CoV-2) test as it gets listed for insurance reimbursement Start from March 6

Feb.17,2020

LSI Medience Launches Testing for Novel Coronavirus

Aug.1,2019

Announcement of Shareholder Change

July.19,2019

LSI Medience Joins the Global Diagnostics Network (GDN)

May.14,2019

Notice Regarding �Life Science Institute Reaches Agreement on Strategic Capital Partnership with PHC Holdings�EAnnounced by Life Science Institute, Inc.